|
2024-09-03 |
2024-08-30 |
B
Purchase
|
Thye Dirk
CEO AND CHIEF MEDICAL OFFICER
Executive Director
|
77,000
+10.0%
0.70
USD 53,900
|
77,000
+10.0%
|
0.70
|
USD 53,900
|
|
|
2024-09-03 |
2024-08-29 |
B
Purchase
|
Thye Dirk
CEO AND CHIEF MEDICAL OFFICER
Executive Director
|
77,500
+11.2%
0.69
USD 53,475
|
77,500
+11.2%
|
0.69
|
USD 53,475
|
|
|
2024-08-21 |
2024-08-21 |
B
Purchase
|
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Officer
|
23,565
+8.6%
0.63
USD 14,846
|
23,565
+8.6%
|
0.63
|
USD 14,846
|
|
|
2024-08-21 |
2024-08-21 |
B
Purchase
|
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Officer
|
5,000
+1.9%
0.62
USD 3,100
|
5,000
+1.9%
|
0.62
|
USD 3,100
|
|
|
2024-08-21 |
2024-08-21 |
B
Purchase
|
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Officer
|
2,280
+0.9%
0.61
USD 1,391
|
2,280
+0.9%
|
0.61
|
USD 1,391
|
|
|
2024-08-22 |
2024-08-20 |
B
Purchase
|
Ryan Charles S.
PRESIDENT
Officer
|
48,387
+65.3%
0.65
USD 31,452
|
48,387
+65.3%
|
0.65
|
USD 31,452
|
|
|
2024-08-21 |
2024-08-20 |
B
Purchase
|
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Officer
|
3,424
+1.3%
0.60
USD 2,054
|
3,424
+1.3%
|
0.60
|
USD 2,054
|
|
|
2024-08-21 |
2024-08-20 |
B
Purchase
|
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Officer
|
2,500
+1.0%
0.61
USD 1,525
|
2,500
+1.0%
|
0.61
|
USD 1,525
|
|
|
2024-08-21 |
2024-08-19 |
B
Purchase
|
Hannah Brendan
CHIEF BUSINESS OFFICER AND COO
Officer
|
2,155
+0.8%
0.58
USD 1,250
|
2,155
+0.8%
|
0.58
|
USD 1,250
|
|
|
2023-12-14 |
2023-12-14 |
B
Purchase
|
Lamond David
Non-Executive Director
|
22,627
+1.0%
1.04
USD 23,532
|
22,627
+1.0%
|
1.04
|
USD 23,532
|
|
|
2023-12-14 |
2023-12-13 |
B
Purchase
|
Lamond David
Non-Executive Director
|
22,627
+1.0%
1.00
USD 22,627
|
22,627
+1.0%
|
1.00
|
USD 22,627
|
|
|
2023-12-14 |
2023-12-12 |
B
Purchase
|
Lamond David
Non-Executive Director
|
22,327
+1.0%
1.02
USD 22,774
|
22,327
+1.0%
|
1.02
|
USD 22,774
|
|
|
2023-12-14 |
2023-12-12 |
B
Purchase
|
Lamond David
Non-Executive Director
|
300
+0.0%
1.00
USD 300
|
300
+0.0%
|
1.00
|
USD 300
|
|
|
2023-12-07 |
2023-12-07 |
B
Purchase
|
Lamond David
Non-Executive Director
|
19,123
+0.8%
1.01
USD 19,314
|
19,123
+0.8%
|
1.01
|
USD 19,314
|
|
|
2023-12-07 |
2023-12-06 |
B
Purchase
|
Lamond David
Non-Executive Director
|
19,123
+0.9%
1.02
USD 19,505
|
19,123
+0.9%
|
1.02
|
USD 19,505
|
|
|
2023-12-07 |
2023-12-05 |
B
Purchase
|
Lamond David
Non-Executive Director
|
19,123
+0.9%
1.01
USD 19,314
|
19,123
+0.9%
|
1.01
|
USD 19,314
|
|
|
2023-12-01 |
2023-12-01 |
B
Purchase
|
Lamond David
Non-Executive Director
|
14,378
+0.7%
0.94
USD 13,515
|
14,378
+0.7%
|
0.94
|
USD 13,515
|
|
|
2023-12-01 |
2023-11-30 |
B
Purchase
|
Lamond David
Non-Executive Director
|
14,378
+0.7%
0.90
USD 12,940
|
14,378
+0.7%
|
0.90
|
USD 12,940
|
|
|
2023-12-01 |
2023-11-29 |
B
Purchase
|
Lamond David
Non-Executive Director
|
14,378
+0.7%
0.98
USD 14,090
|
14,378
+0.7%
|
0.98
|
USD 14,090
|
|
|
2023-08-31 |
2023-08-31 |
B
Purchase
|
Lamond David
Non-Executive Director
|
41,026
+1.9%
1.32
USD 54,154
|
41,026
+1.9%
|
1.32
|
USD 54,154
|
|
|
2023-08-31 |
2023-08-30 |
B
Purchase
|
Lamond David
Non-Executive Director
|
41,026
+2.0%
1.31
USD 53,744
|
41,026
+2.0%
|
1.31
|
USD 53,744
|
|
|
2023-08-17 |
2023-08-17 |
B
Purchase
|
Lamond David
Non-Executive Director
|
24,766
+1.2%
1.29
USD 31,948
|
24,766
+1.2%
|
1.29
|
USD 31,948
|
|
|
2023-08-17 |
2023-08-16 |
B
Purchase
|
Lamond David
Non-Executive Director
|
117,348
+6.0%
1.29
USD 151,379
|
117,348
+6.0%
|
1.29
|
USD 151,379
|
|
|
2023-08-17 |
2023-08-15 |
B
Purchase
|
Lamond David
Non-Executive Director
|
107,886
+5.8%
1.32
USD 142,410
|
107,886
+5.8%
|
1.32
|
USD 142,410
|
|
|
2023-08-11 |
2023-08-10 |
B
Purchase
|
Thye Dirk
Chief Executive Officer
Executive Director
|
88,000
+24.4%
1.26
USD 110,880
|
88,000
+24.4%
|
1.26
|
USD 110,880
|
|
|
2023-08-09 |
2023-08-08 |
B
Purchase
|
Thye Dirk
Chief Executive Officer
Executive Director
|
80,000
+28.5%
1.24
USD 99,200
|
80,000
+28.5%
|
1.24
|
USD 99,200
|
|
|
2023-08-09 |
2023-08-08 |
B
Purchase
|
Hannah Brendan
Chief Business Officer
Officer
|
71,762
+55.3%
1.22
USD 87,550
|
71,762
+55.3%
|
1.22
|
USD 87,550
|
|
|
2023-08-09 |
2023-08-08 |
B
Purchase
|
McLoughlin Margaret
Non-Executive Director
|
8,000
+inf%
1.23
USD 9,840
|
8,000
+inf%
|
1.23
|
USD 9,840
|
|
|
2023-03-06 |
2023-03-06 |
PS
Planned sale
|
Monohon Ted
Chief Accounting Officer & VP
Officer
|
1,871
-6.4%
0.98
USD 1,834
|
1,871
-6.4%
|
0.98
|
USD 1,834
|
|
|
2022-06-08 |
2022-06-06 |
S
Sale
|
McDowell Caryn Gordon
Chief Legal & Adm. Officer
Officer
|
10,800
-8.1%
2.86
USD 30,923
|
10,800
-8.1%
|
2.86
|
USD 30,923
|
|
|
2021-11-12 |
2021-11-12 |
B
Purchase
|
Dominy Stephen S.
Chief Scientific Officer
Executive Director
|
763
+0.1%
14.40
USD 10,987
|
763
+0.1%
|
14.40
|
USD 10,987
|
|
|
2021-10-12 |
2021-10-08 |
PS
Planned sale
|
McLoughlin Margaret
Non-Executive Director
|
1,000
-100.0%
88.93
USD 88,930
|
1,000
-100.0%
|
88.93
|
USD 88,930
|
|
|
2021-10-07 |
2021-10-05 |
PS
Planned sale
|
LOWE CHRISTOPHER P.
COO & Chief Financial Officer
Officer
|
4,963
-7.6%
98.50
USD 488,856
|
4,963
-7.6%
|
98.50
|
USD 488,856
|
|
|
2021-07-07 |
2021-07-07 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
523
-100.0%
56.99
USD 29,806
|
523
-100.0%
|
56.99
|
USD 29,806
|
|
|
2021-07-07 |
2021-07-07 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
6,942
-93.0%
56.27
USD 390,626
|
6,942
-93.0%
|
56.27
|
USD 390,626
|
|
|
2021-07-07 |
2021-07-07 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
4,353
-36.8%
55.38
USD 241,069
|
4,353
-36.8%
|
55.38
|
USD 241,069
|
|
|
2021-07-07 |
2021-07-07 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
1,648
-12.2%
54.37
USD 89,602
|
1,648
-12.2%
|
54.37
|
USD 89,602
|
|
|
2021-07-07 |
2021-07-07 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
3,934
-22.6%
53.24
USD 209,446
|
3,934
-22.6%
|
53.24
|
USD 209,446
|
|
|
2021-07-07 |
2021-07-06 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
288
-100.0%
55.01
USD 15,843
|
288
-100.0%
|
55.01
|
USD 15,843
|
|
|
2021-07-07 |
2021-07-06 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
8,260
-96.6%
53.91
USD 445,297
|
8,260
-96.6%
|
53.91
|
USD 445,297
|
|
|
2021-07-07 |
2021-07-06 |
PS
Planned sale
|
Detke Michael J.
Chief Medical Officer
Officer
|
32,313
-79.1%
53.43
USD 1,726,484
|
32,313
-79.1%
|
53.43
|
USD 1,726,484
|
|
|
2021-05-12 |
2021-05-10 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
183
-0.0%
36.73
USD 6,722
|
183
-0.0%
|
36.73
|
USD 6,722
|
|
|
2021-05-12 |
2021-05-10 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
6,315
-0.6%
35.81
USD 226,140
|
6,315
-0.6%
|
35.81
|
USD 226,140
|
|
|
2021-05-12 |
2021-05-10 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
9,918
-1.0%
34.89
USD 346,039
|
9,918
-1.0%
|
34.89
|
USD 346,039
|
|
|
2021-05-12 |
2021-05-10 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
13,584
-1.3%
33.75
USD 458,460
|
13,584
-1.3%
|
33.75
|
USD 458,460
|
|
|
2021-03-24 |
2021-03-24 |
B
Purchase
|
Lamond David
Non-Executive Director
|
50,000
+2.8%
33.77
USD 1,688,500
|
50,000
+2.8%
|
33.77
|
USD 1,688,500
|
|
|
2021-03-23 |
2021-03-22 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
400
-0.0%
36.60
USD 14,640
|
400
-0.0%
|
36.60
|
USD 14,640
|
|
|
2021-03-23 |
2021-03-22 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
300
-0.0%
36.58
USD 10,974
|
300
-0.0%
|
36.58
|
USD 10,974
|
|
|
2021-03-23 |
2021-03-22 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
18,089
-1.8%
35.85
USD 648,491
|
18,089
-1.8%
|
35.85
|
USD 648,491
|
|
|
2021-03-23 |
2021-03-22 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
11,211
-1.1%
35.10
USD 393,506
|
11,211
-1.1%
|
35.10
|
USD 393,506
|
|
|
2021-03-05 |
2021-03-04 |
B
Purchase
|
Lamond David
Non-Executive Director
|
4,100
+0.2%
36.86
USD 151,126
|
4,100
+0.2%
|
36.86
|
USD 151,126
|
|
|
2021-03-05 |
2021-03-04 |
B
Purchase
|
Lamond David
Non-Executive Director
|
15,969
+0.9%
36.34
USD 580,313
|
15,969
+0.9%
|
36.34
|
USD 580,313
|
|
|
2021-03-05 |
2021-03-04 |
B
Purchase
|
Lamond David
Non-Executive Director
|
13,310
+0.8%
35.00
USD 465,850
|
13,310
+0.8%
|
35.00
|
USD 465,850
|
|
|
2021-03-05 |
2021-03-04 |
B
Purchase
|
Lamond David
Non-Executive Director
|
16,621
+1.0%
34.28
USD 569,768
|
16,621
+1.0%
|
34.28
|
USD 569,768
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
600
-0.1%
45.73
USD 27,438
|
600
-0.1%
|
45.73
|
USD 27,438
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
8,032
-0.8%
45.00
USD 361,440
|
8,032
-0.8%
|
45.00
|
USD 361,440
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
1,900
-0.2%
44.22
USD 84,018
|
1,900
-0.2%
|
44.22
|
USD 84,018
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
1,512
-0.1%
43.10
USD 65,167
|
1,512
-0.1%
|
43.10
|
USD 65,167
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
3,100
-0.3%
41.91
USD 129,921
|
3,100
-0.3%
|
41.91
|
USD 129,921
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
2,000
-0.2%
40.84
USD 81,680
|
2,000
-0.2%
|
40.84
|
USD 81,680
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
856
-0.1%
39.82
USD 34,086
|
856
-0.1%
|
39.82
|
USD 34,086
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
1,600
-0.2%
38.64
USD 61,824
|
1,600
-0.2%
|
38.64
|
USD 61,824
|
|
|
2021-02-03 |
2021-02-03 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
400
-0.0%
37.39
USD 14,956
|
400
-0.0%
|
37.39
|
USD 14,956
|
|
|
2021-02-03 |
2021-02-02 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
5,071
-0.5%
36.75
USD 186,359
|
5,071
-0.5%
|
36.75
|
USD 186,359
|
|
|
2021-02-03 |
2021-02-02 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
14,929
-1.4%
36.02
USD 537,743
|
14,929
-1.4%
|
36.02
|
USD 537,743
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
371
-0.0%
39.23
USD 14,554
|
371
-0.0%
|
39.23
|
USD 14,554
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
100
-0.0%
38.28
USD 3,828
|
100
-0.0%
|
38.28
|
USD 3,828
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
4,283
-0.4%
37.68
USD 161,383
|
4,283
-0.4%
|
37.68
|
USD 161,383
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
7,460
-0.7%
36.56
USD 272,738
|
7,460
-0.7%
|
36.56
|
USD 272,738
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
3,100
-0.3%
35.59
USD 110,329
|
3,100
-0.3%
|
35.59
|
USD 110,329
|
|
|
2021-02-03 |
2021-02-01 |
PS
Planned sale
|
Lynch Casey
Chief Executive Officer
Executive Director
|
4,686
-0.4%
34.60
USD 162,136
|
4,686
-0.4%
|
34.60
|
USD 162,136
|
|
|
2020-12-15 |
2020-12-14 |
PS
Planned sale
|
Holsinger Leslie
Executive Vice President
Officer
|
900
-20.5%
32.59
USD 29,331
|
900
-20.5%
|
32.59
|
USD 29,331
|
|
|
2020-12-15 |
2020-12-14 |
PS
Planned sale
|
Holsinger Leslie
Executive Vice President
Officer
|
400
-8.3%
32.59
USD 13,034
|
400
-8.3%
|
32.59
|
USD 13,034
|
|
|
2020-12-15 |
2020-12-14 |
PS
Planned sale
|
Holsinger Leslie
Executive Vice President
Officer
|
9,525
-84.1%
31.79
USD 302,800
|
9,525
-84.1%
|
31.79
|
USD 302,800
|
|
|
2020-12-15 |
2020-12-14 |
PS
Planned sale
|
Holsinger Leslie
Executive Vice President
Officer
|
13,200
-48.0%
30.91
USD 408,012
|
13,200
-48.0%
|
30.91
|
USD 408,012
|
|
